Clinical Evidence: How 1mg Wegovy Compares to Mounjaro
Weight Loss Results UK: 1mg Wegovy to Mounjaro Clinical Comparison
When comparing 1mg Wegovy to Mounjaro for UK patients, understanding the clinical evidence is essential. The STEP trials demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, with significant results emerging during the 1mg phase (weeks 9-12). Mounjaro operates through a dual mechanism, targeting both GIP and GLP-1 receptors compared to Wegovy's single GLP-1 approach.
Both treatments require prescription assessment and cannot be directly compared through head-to-head trials due to different study populations and endpoints. However, the 1mg Wegovy dose represents a critical escalation point where appetite regulation typically becomes well-established. UK patients transitioning from 1mg Wegovy to Mounjaro considerations often focus on injection frequency, storage requirements, and individual response patterns observed during their initial treatment months.
1mg Wegovy to Mounjaro Pricing: Complete UK Cost Analysis
EverydayMeds offers transparent pricing for both 1mg Wegovy to Mounjaro options, with single 1mg Wegovy pens priced at £99.99. Our Advance Duo bundle (1mg + 1.7mg Wegovy) costs £269.99, providing seamless progression to higher doses. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 for their ongoing treatment. These discount codes are applied to reach our competitive final pricing structure.
The Consistency 1mg bundle (two 1mg pens) costs £209.99, ideal for patients who respond well to this dose and want extended treatment duration. When comparing 1mg Wegovy to Mounjaro costs, both treatments require similar clinical assessment fees and delivery arrangements. Our pricing includes full clinical review, prescription processing, and next-day cold-chain delivery to ensure medication integrity throughout the UK supply chain.
STEP Trial Evidence: 1mg Wegovy to Mounjaro Effectiveness
The landmark STEP trials, published by Wilding et al. in NEJM 2021, provide robust evidence for Wegovy's effectiveness at the 1mg dose level. STEP 1 demonstrated approximately 15% average weight loss over 68 weeks, with STEP 3 showing 16% when combined with intensive behavioural therapy. These results occurred in patients taking Wegovy alongside reduced-calorie diets and increased physical activity.
STEP 5 confirmed sustained weight loss of approximately 15.2% at two years, indicating long-term effectiveness. The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major cardiovascular events, providing additional health benefits beyond weight management. When considering 1mg Wegovy to Mounjaro transitions, these evidence-based results inform clinical decision-making for UK prescribers.
How Wegovy Works: GLP-1 Mechanism in 1mg Dosing
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones produced in the intestine. At 1mg dosing, the medication effectively reduces appetite by acting on brain appetite centres, promoting feelings of fullness after smaller meals. The once-weekly injection maintains steady therapeutic levels, supporting consistent appetite regulation throughout each dosing interval. Patients typically report reduced food cravings and improved portion control during the 1mg phase, which spans weeks 9-12 of treatment. This mechanism differs from Mounjaro's dual GIP/GLP-1 approach, though both target similar appetite and satiety pathways for weight management support.
Ordering Process: 1mg Wegovy to Mounjaro Assessment
EverydayMeds streamlines the ordering process for both 1mg Wegovy and Mounjaro through our comprehensive online clinical assessment, completed in approximately three minutes. Our qualified prescribers review all submissions within three working days (or 24 hours with express service), ensuring appropriate prescription decisions for individual patient circumstances. Once approved, medications are dispatched via next-day delivery using temperature-controlled cold-chain logistics. The assessment covers medical history, current medications, weight management goals, and contraindications for both treatment options. This process ensures compliance with MHRA guidelines and NICE recommendations for specialist weight management support.
Storage Considerations: 1mg Wegovy to Mounjaro Practical Differences
Storage requirements present a key practical difference when comparing 1mg Wegovy to Mounjaro options for UK patients. Wegovy maintains stability for up to six weeks at room temperature (below 30°C) once removed from refrigerated storage, compared to Mounjaro's 21-day room temperature limit. Both medications require initial refrigerated storage at 2-8°C before first use, delivered in temperature-controlled packaging. The FlexTouch pen design provides precise 1mg dosing with clear visual confirmation of injection completion. Wegovy's extended room temperature stability offers advantages for travel, work schedules, and lifestyle flexibility during the critical 1mg escalation phase. This storage convenience factor influences many patients when considering treatment continuation or switching between options.
1mg Wegovy to Mounjaro: UK Patient Response Patterns
Clinical experience with 1mg Wegovy to Mounjaro comparisons reveals distinct patient response patterns across UK populations. The 1mg Wegovy dose typically represents weeks 9-12 of treatment, where appetite suppression becomes well-established and patients report measurable progress toward their weight management goals. Some patients achieve their target response at this dose level, whilst others continue escalating toward the 2.4mg maintenance dose as clinically indicated.
Mounjaro's dual receptor mechanism may appeal to patients seeking alternative approaches after completing Wegovy dose escalation or those requiring different injection schedules. Both treatments require prescription-only medicine oversight and ongoing clinical monitoring throughout the weight management journey. UK prescribers evaluate individual response patterns, side effect profiles, and lifestyle factors when recommending continuation or switching between these evidence-based options.
Complete Your Weight Management Journey: 1mg Wegovy to Mounjaro Options
Ready to progress your weight management journey with evidence-based treatment? EverydayMeds supplies both 1mg Wegovy and Mounjaro through our GPhC-registered pharmacy (#9012878), ensuring regulatory compliance and clinical safety for UK patients. New customers use code FIRST40 at checkout, whilst returning patients apply DOSE25 for continued savings on their prescription-only medicine orders. Our clinical team provides ongoing support throughout your treatment progression, whether continuing Wegovy dose escalation or exploring Mounjaro alternatives. Begin your clinical assessment today to determine which option aligns with your individual weight management goals. Visit our secure ordering platform to start the process with complete confidence in our professional pharmacy services.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
